Erratum: Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells (PLoS ONE (2014) 9:1 (e87769) DOI:10.1371/journal.pone.0087769);Simvastatin impairs growth hormone-activated signal transducer and activator of transcription (STAT) signaling pathway in UMR-106 osteosarcoma cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Sandoval Usme, María Claudia ^a   Umaña Pérez, Adriana ^a   Guerra, Borja ^b,c   Hernández Perera, Orlando ^d   García Castellano, José Manuel ^d   Fernández Pérez, Leandro ^b,c   Sánchez Gómez, Myriam ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^c CSIC   (Spain)

^d HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; JANUS KINASE; JANUS KINASE 2; SIMVASTATIN; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; NONHUMAN; OSTEOSARCOMA CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH HORMONE; HUMANS; JANUS KINASES; OSTEOSARCOMA; RATS; RATS, INBRED BUF; SIGNAL TRANSDUCTION; SIMVASTATIN; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84896290135     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091619     Document Type: Erratum

References (44)

1. Parsons RB, Price GC, Farrant JK, Subramaniam D, Adeagbo-Sheikh J, et al. (2006) Statins inhibit the dimerization of beta-secretase via both isoprenoid- and cholesterol-mediated mechanisms. Biochem J 399: 205-214. (Pubitemid 44570282)
2. Karlsson R, Pedersen ED, Wang Z, Brakebusch C (2009) Rho GTPase function in tumorigenesis. Biochim Biophys Acta 1796: 91-98.
3. Kodach LL, Bleuming SA, Peppelenbosch MP, Hommes DW, van den Brink GR, et al. (2007) The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Gastroenterology 133: 1272-1281. (Pubitemid 47494465)
4. Oliveira KA, Zecchin KG, Alberici LC, Castilho RF, Vercesi AE (2008) Simvastatin inducing PC3 prostate cancer cell necrosis mediated by calcineurin and mitochondrial dysfunction. J Bioenerg Biomembr 40: 307-314.
5. Gbelcova H, Lenicek M, Zelenka J, Knejzlik Z, Dvorakova G, et al. (2008) Differences in antitumor effects of various statins on human pancreatic cancer. Int J Cancer 122: 1214-1221. (Pubitemid 351287219)
6. Koyuturk M, Ersoz M, Altiok N (2007) Simvastatin induces apoptosis in human breast cancer cells: p53 and estrogen receptor independent pathway requiring signalling through JNK. Cancer Lett 250: 220-228. (Pubitemid 46529446)
7. Glynn SA, O'Sullivan D, Eustace AJ, Clynes M, O'Donovan N (2008) The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells. BMC Cancer 8: 9.
8. Fromigue O, Hamidouche Z, Marie PJ (2008) Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs. J Pharmacol Exp Ther 325: 595-600. (Pubitemid 351574795)
9. Smirnova OV, Ostroukhova TY, Bogorad RL (2007) JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression? World J Gastroenterol 13: 6478-6491.
10. Deng JY, Sun D, Liu XY, Pan Y, Liang H (2010) STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol 16: 5380-5387.
11. Bowman T, Garcia R, Turkson J, Jove R (2000) STATs in oncogenesis. Oncogene 19: 2474-2488. (Pubitemid 30339203)
12. Spano JP, Milano G, Rixe C, Fagard R (2006) JAK/STAT signalling pathway in colorectal cancer: a new biological target with therapeutic implications. Eur J Cancer 42: 2668-2670. (Pubitemid 44584670)
13. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, et al. (1997) Structure and function of a new STAT-induced STAT inhibitor. Nature 387: 924-929. (Pubitemid 27289596)
14. Babon JJ, Sabo JK, Soetopo A, Yao S, Bailey MF, et al. (2008) The SOCS box domain of SOCS3: structure and interaction with the elonginBC-cullin5 ubiquitin ligase. J Mol Biol 381: 928-940.
15. Liu J, Shen Q, Wu Y (2008) Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway. Life Sci 82: 991-996.
16. Jougasaki M, Ichiki T, Takenoshita Y, Setoguchi M (2010) Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. Br J Pharmacol 159: 1294-1303.
17. Huang KC, Chen CW, Chen JC, Lin WW (2003) Statins induce suppressor of cytokine signaling-3 in macrophages. FEBS Lett 555: 385-389.
18. Zhang X, Jin J, Peng X, Ramgolam VS, Markovic-Plese S (2008) Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. J Immunol 180: 6988-6996.
19. Barnard R, Ng KW, Martin TJ, Waters MJ (1991) Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 128: 1459-1464.
20. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19: 55-79. (Pubitemid 29122074)
21. Lima GA, Gomes EM, Nunes RC, Vieira Neto L, Sieiro AP, et al. (2006) Osteosarcoma and acromegaly: a case report and review of the literature. J Endocrinol Invest 29: 1006-1011. (Pubitemid 46344236)
22. Gallagher EJ, LeRoith D (2011) Is growth hormone resistance/IGF-1 reduction good for you? Cell Metab 13: 355-356.
23. Morales O, Lindgren U, Haldosen LA (2000) Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells. J Bone Miner Res 15: 2284-2290.
24. Sandoval-Usme MC, Ordóñez N, Umaña-Pérez A, Fernández-Pérez L, Sánchez-Gómez M (2011) Anti-tumor effects of simvastatin on UMR 106 osteosarcoma cell line. Rev Acad Colomb Cienc 35: 287-294.
25. Cabrera-Benitez NE (2008) Papel de los inhibidores de la 3-hidroxi-3-metilglutaril coenzima A reductasa (estatinas) en las líneas celulares de osteosarcoma. Estudio In vitro. Las Palmas de Gran CanariaGran Canaria, Spain: Universidad de Las Palmas de Gran Canaria. 141 p.
26. Fernandez L, Flores-Morales A, Lahuna O, Sliva D, Norstedt G, et al. (1998) Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C. Endocrinology 139: 1815-1824. (Pubitemid 28513842)
27. Soule HD, Vazguez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416.
28. Solly K, Wang X, Xu X, Strulovici B, Zheng W (2004) Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol 2: 363-372. (Pubitemid 39276278)
29. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942. (Pubitemid 17027905)
30. Yamashita H, Xu J, Erwin RA, Farrar WL, Kirken RA, et al. (1998) Differential control of the phosphorylation state of proline-juxtaposed serine residues Ser725 of Stat5a and Ser730 of Stat5b in prolactin-sensitive cells. J Biol Chem 273: 30218-30224. (Pubitemid 28545486)
31. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45.
32. Mitra A, Ross JA, Rodriguez G, Nagy ZS, Wilson HL, et al. (2012) Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies. J Biol Chem 287: 16596-16608.
33. Goldstein JL, Brown MS (1990) Regulation of the mevalonate pathway. Nature 343: 425-430.
34. Mantha AJ, McFee KE, Niknejad N, Goss G, Lorimer IA, et al. (2003) Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells. J Cancer Res Clin Oncol 129: 631-641. (Pubitemid 37452629)
35. Robles-Valero J, Martin-Cofreces NB, Lamana A, Macdonald S, Volkov Y, et al. (2010) Integrin and CD3/TCR activation are regulated by the scaffold protein AKAP450. Blood 115: 4174-4184.
36. Collisson EA, Kleer C, Wu M, De A, Gambhir SS, et al. (2003) Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. Mol Cancer Ther 2: 941-948.
37. Park SH, Yamashita H, Rui H, Waxman DJ (2001) Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity. Mol Endocrinol 15: 2157-2171. (Pubitemid 33141135)
38. Nagy ZS, Wang Y, Erwin-Cohen RA, Aradi J, Monia B, et al. (2002) Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways. J Leukoc Biol 72: 819-828. (Pubitemid 36277854)
39. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, et al. (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387: 917-921. (Pubitemid 27289594)
40. Cooper JC, Shi M, Chueh FY, Venkitachalam S, Yu CL (2010) Enforced SOCS1 and SOCS3 expression attenuates Lck-mediated cellular transformation. Int J Oncol 36: 1201-1208.
41. Ahmed SF, Farquharson C (2010) The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteins. J Endocrinol 206: 249-259.
42. Wormald S, Hilton DJ (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279: 821-824. (Pubitemid 38082600)
43. Morales O, Faulds MH, Lindgren UJ, Haldosen LA (2002) 1Alpha,25-dihydroxyvitamin D3 inhibits GH-induced expression of SOCS-3 and CIS and prolongs growth hormone signaling via the Janus kinase (JAK2)/signal transducers and activators of transcription (STAT5) system in osteoblast-like cells. J Biol Chem 277: 34879-34884.
44. Ram PA, Waxman DJ (1999) SOCS/CIS protein inhibition of growth hormone-stimulated STAT5 signaling by multiple mechanisms. J Biol Chem 274: 35553-35561. (Pubitemid 129512851)